Jaguar Health, Inc.
JAGX
$12.98
$1.119.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -9.92M | -9.85M | -9.49M | -9.23M | -9.17M |
| Total Depreciation and Amortization | 593.00K | 596.00K | 559.00K | 610.00K | 591.00K |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 0.00 | 274.00K | 1.71M |
| Total Other Non-Cash Items | 2.94M | 3.10M | 2.00M | 1.45M | 2.75M |
| Change in Net Operating Assets | -1.44M | -178.00K | -1.24M | -153.00K | -3.33M |
| Cash from Operations | -7.83M | -6.34M | -8.17M | -7.05M | -7.45M |
| Capital Expenditure | 0.00 | 0.00 | -16.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -215.00K | -- | -- | -- | -- |
| Cash from Investing | -215.00K | 0.00 | -16.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -171.00K | -221.00K | -94.00K | -222.00K | -610.00K |
| Issuance of Common Stock | 3.03M | 3.77M | 12.74M | 12.53M | 10.08M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -30.00K | -18.00K | -67.00K | -42.00K | 1.18M |
| Cash from Financing | 2.83M | 3.53M | 12.57M | 12.27M | 10.65M |
| Foreign Exchange rate Adjustments | -56.00K | 31.00K | -10.00K | -19.00K | 44.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.27M | -2.78M | 4.38M | 5.20M | 3.24M |